The Emerging Clinical Application of m6A RNA Modification in Inflammatory Bowel Disease and Its Associated Colorectal Cancer
Xinwei Xu,1,* Jintu Huang,2,* Dickson Kofi Wiredu Ocansey,1,3 Yuxuan Xia,1 Zihan Zhao,1 Zhiwei Xu,1 Yongmin Yan,1 Xu Zhang,1 Fei Mao1 1Department of Clinical Laboratory Diagnostics, Key Laboratory of Medical Science and Laboratory Medicine of Jiangsu Province, School of Medicine, Jia...
Guardado en:
Autores principales: | Xu X, Huang J, Ocansey DKW, Xia Y, Zhao Z, Xu Z, Yan Y, Zhang X, Mao F |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ff7128db0cae4359be8278b80b0f15b4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Mucin-Type O-Glycans: Barrier, Microbiota, and Immune Anchors in Inflammatory Bowel Disease
por: Zhang Y, et al.
Publicado: (2021) -
Multifocal colorectal non-Hodgkin's lymphoma in a patient with ulcerative colitis: A case report
por: Sagar Walinjkar, et al.
Publicado: (2021) -
Application of Artificial Intelligence Modeling Technology Based on Multi-Omics in Noninvasive Diagnosis of Inflammatory Bowel Disease
por: Huang Q, et al.
Publicado: (2021) -
Combined Use of Fecal Biomarkers in Inflammatory Bowel Diseases: Oncostatin M and Calprotectin
por: Cao Y, et al.
Publicado: (2021) -
Enhancement of Circulating and Intestinal T Regulatory Cells and Their Expression of Helios and Neuropilin-1 in Children with Inflammatory Bowel Disease
por: Sznurkowska K, et al.
Publicado: (2020)